2002-2005

2005 - Pursaethosides A-E, triterpene saponins from Entada pursaetha

A.L. Tapondjou, T. Miyamoto, J-F. Mirjolet, N. Guilbaud and M.A. Lacaille-Dubois
J. Nat. Prod., 2005 Aug 26, 68(8): 1185-1190

2005 - A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

M. Tychopoulos, L. Corcos, P. Genne, P. Beaune and I. de Waziers
Cancer Gene Ther., 2005 May, 12(5): 497-508

2005 - Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

D. McKillop, E.A. Partridge, J.V. Kemp, M.P. Spence, J. Kendrew, S. Barnett, P.G. Wood, P.B. Giles,
A.B. Patterson, F. Bichat, N. Guilbaud and T.C. Stephens
Mol. Cancer Ther., 2005 Apr, 4(4): 641-9

2005 - Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors

J.A. Becker, J.F. Mirjolet, J. Bernard, E. Burgeon, M.J. Simons, G. Vassart, M. Parmentier and F. Libert
Biochem. Biophys. Res. Commun., 2005 Jan 21, 326(3): 677-86

2005 - Role of non invasive animal imaging in preclinical anticancer drug development (French review)

N. Guilbaud, O. Duchamp, N. Just and P. Genne
Bulletin du Cancer, 2005, 92(1): 45-57

2003 - Characterization of human Smg5/7a: a protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1

S.Y. Chiu, G. Serin, O. Ohara and L.E. Maquat
RNA, 2003 Jan, 9(1): 77-87

2003 - Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives (Review)

B. Chauffert, P. Favoulet, E. Polycarpe, C. Duvillard, J.L. Beltramo, F. Bichat, P. Rat, P. Genne and L. Benoit
Surg. Oncol. Clin. N. Am., 2003 Jul, 12(3): 835-48

2003 - Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines

C. Didelot, J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci, M.H. Teiten and J.L. Merlin
Int. J. Oncol., 2003 Jul, 23(1): 81-7

2003 - Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley,
C. Blanpain, M. Detheux, A. Mantovani, S. Sozzani, G. Vassart, M. Parmentier and D. Communi
J. Exp. Med., 2003 Oct 6, 198(7): 977-85

2002 - Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies

O. Mazor, M. Hillairet de Boisferon, A. Lombet, A. Gruaz-Guyon, B. Gayer, D. Skrzydelsky, F. Kohen,
P. Forgez, A. Scherz, W. Rostène and Y. Salomon
Analytical Biochemistry, 2002 Feb 1, 301(1): 75-81

2002 - G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity

J.F. Mirjolet, C. Didelot, M. Barberi-Heyob and J.L. Merlin
Cytometry, 2002 May 1, 48(1): 6-13

2002 - Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model

M. Hillairet de Boisferon., O. Raguin, C. Thiercelin, M. Dussaillant, W. Rostène, J. Barbet,
A. Pélegrin and A. Gruaz-Guyon
Bioconjug. Chem., 2002 May-Jun, 13(3): 654-62

2002 - Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells

C. Didelot, J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci and J.L. Merlin
Canadian Journal of Physiological Pharmacology, 2002 Jul, 80(7): 638-43

2002 - Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts

H. Gourdeau, P. Genne, S. Kadhim, L. Bibeau, O. Duchamp, F. Ouellet, J.M. deMuys, D.Y. Bouffard and G. Attardo
Cancer Chemotherapy Pharmacology, 2002 Dec, 50(6): 490-6

Actualités

2002-2005

A propos d’Oncodesign

Nos offres

Notre modèle d’innovation

Nos technologies

Investisseurs

Carrières

Actualités

Contact

Actualités

2002-2005

S'inscrire à la lettre d'information générale